Dealings Round-Up

Director dealings: Genedrive CEO raises stake

By Iain Gilbert

Date: Tuesday 01 Sep 2026

(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Miele, who took over as CEO in August 2024, purchased the shares at an average price of 1.38p each, for a total value of £9,660.

Following the...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page